Switzerland’s burgeoning pharmaceutical sales to the United States have become a central factor behind Bern’s widening trade surplus, according to a Bloomberg report highlighting the country’s export profile. US Trade Representative Greer said talks aimed at addressing the imbalance have proven “challenging,” noting that Switzerland ships a substantial volume of medicines to the American market. Greer added that the latest round of discussions ended without an agreement, underscoring persistent friction in the bilateral trade relationship.